We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Interpretable AI Reveals Hidden Cellular Features from Microscopy Images

By LabMedica International staff writers
Posted on 24 Apr 2026

Microscopy images contain rich clues about cell health, but many disease-relevant morphological differences are too subtle to see and difficult to quantify consistently. More...

Artificial intelligence (AI) has helped, yet many models function as opaque “black boxes,” limiting trust and reproducibility in clinical workflows. More transparent tools that expose which visual features drive decisions could accelerate reliable single‑cell phenotyping. A new study shows an interpretable AI framework that learns reusable morphological features from cell images to better characterize cellular states.

At The University of Hong Kong (HKU), researchers developed MorphoGenie, an AI framework designed to analyze individual-cell images and reveal subtle but meaningful patterns linked to identity, state, and behavior. Unlike conventional models, MorphoGenie is built for interpretability, enabling users to see which image features underpin each prediction. The system learns a compact set of reusable “building blocks”—including cell size and shape, broad internal texture, and fine local details—and recombines them to describe diverse cellular conditions.

MorphoGenie applies the AI principle of compositionality to cell morphology, learning concepts directly from images rather than relying on manual labels or hand‑crafted features. The framework organizes complex image information into a concise, human-understandable representation. It functions across multiple microscopy modalities, including label‑free quantitative phase imaging and fluorescence microscopy, and can transfer learned features from one dataset to previously unseen datasets.

In demonstrations, the HKU team showed that MorphoGenie distinguished major lung cancer cell subtypes, detected drug‑induced morphological changes, and tracked dynamic processes such as cell‑cycle progression and epithelial‑to‑mesenchymal transition. The work is published in Nature Communications. The approach is positioned to support more transparent analyses in biomedicine, where trust, reproducibility, and scientific insight are essential.

“One of the long-term goals of AI is to build systems that learn from reusable concepts, rather than simply memorizing patterns. Humans do this naturally—we understand the world by combining simple ideas into more complex ones. MorphoGenie applies a similar principle to cell morphology, helping to make AI more transparent, adaptable and potentially more useful for future disease diagnostics,” said Professor Kevin Tsia, Department of Electrical and Computer Engineering and Program Director of the Biomedical Engineering Program, The University of Hong Kong.

"Cell images contain much richer information than what we can easily describe using conventional measurements alone," said Dr. Rashmi Sreeramachandra Murthy, the first author of the study. "By learning interpretable visual primitives, MorphoGenie helps reveal meaningful biological patterns that might otherwise remain hidden, while still allowing researchers to understand what the AI is using to interpret the data."

Related Links
University of Hong Kong


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: FDA approval enables the OncoMate MSI Dx Analysis System to identify patients who may benefit from Merck’s KEYTRUDA anti-PD-1 therapy. (Photo courtesy of Promega)

Microsatellite Instability Test Gains FDA Approval for Immunotherapy Selection

Microsatellite instability-high (MSI-H) status is a key tumor biomarker used to guide treatment decisions in precision oncology. Testing can identify adult and pediatric patients with unresectable or metastatic... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.